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What is already known about the topic?
•• User involvement (i.e. involvement of patients, their unpaid caregivers and the public) is increasingly seen as essential for all 
stages of high-quality research.
•• User involvement in palliative care is limited by a lack of evidence on its goals and  on the best models to implement.
What this paper adds?
•• In palliative care research, patient and public involvement should occur early during the research process; it should be 
applied flexibly and offered both via virtual and face-to-face methods.
Results of a transparent expert  
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Abstract
Background: Support and evidence for patient, unpaid caregiver and public involvement in research (user involvement) are growing. 
Consensus on how best to involve users in palliative care research is lacking.
Aim: To determine an optimal user-involvement model for palliative care research.
Design: We hosted a consultation workshop using expert presentations, discussion and nominal group technique to generate 
recommendations and consensus on agreement of importance. A total of 35 users and 32 researchers were approached to attend the 
workshop, which included break-out groups and a ranking exercise. Descriptive statistical analysis to establish consensus and highlight 
divergence was applied. Qualitative analysis of discussions was completed to aid interpretation of findings.
Setting/participants: Participants involved in palliative care research were invited to a global research institute, UK.
Results: A total of 12 users and 5 researchers participated. Users wanted their involvement to be more visible, including during 
dissemination, with a greater emphasis on the difference their involvement makes. Researchers wanted to improve productivity, 
relevance and quality through involvement. Users and researchers agreed that an optimal model should consist of (a) early involvement 
to ensure meaningful involvement and impact and (b) diverse virtual and face-to-face involvement methods to ensure flexibility.
Conclusion: For involvement in palliative care research to succeed, early and flexible involvement is required. Researchers should 
advertise opportunities for involvement and promote impact of involvement via dissemination plans. Users should prioritise adding 
value to research through enhancing productivity, quality and relevance. More research is needed not only to inform implementation 
and ensure effectiveness but also to investigate the cost-effectiveness of involvement in palliative care research.
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•• Researchers must promote the contribution that patients, their unpaid caregivers and the public deliver, emphasise the dif-
ference that they make and enable user dissemination.
•• Patient and public involvement can help demystify palliative care and raise awareness about palliative care research. 
•• Patients, their unpaid caregivers and the public require guidance and encouragement from researchers on how to help 
improve research productivity, quality and relevance.
Implications for practice, theory or policy
•• User-involvement practice in palliative care research should be characterised by early involvement facilitated by diverse 
virtual and face-to-face methods, and user visibility. User visibility should be stressed, especially in research dissemination. 
Patients, their unpaid caregivers and the public require guidance and encouragement from researchers on how to help 
improve research productivity, quality and relevance. Implementation, effectiveness and cost-effectiveness research is 
required to examine outcomes of user-involvement models.
Introduction
Patients, their unpaid caregivers and the public have a key 
role to play in improving research quality, relevance, fund-
ing and dissemination. National and international research 
authorities advocate patient and public involvement in 
research to increase research responsiveness and quality, 
and increase public engagement in research thereby creat-
ing research-active nations.1–3 Patient and public involve-
ment, which comprises active participation of patients, 
their unpaid caregivers and the public in research (e.g. in 
the design review and development of recruitment strate-
gies), is increasingly seen as an essential component to 
‘good’ research practice. Patient and public involvement is 
referred to in the literature in a number of different ways, 
including consumer involvement and user involvement.4,5
The evidence base for patient and public involvement 
in health research and within palliative and end-of-life care 
is expanding. Moderate quality trial evidence has shown 
that involvement can result in more relevant, readable and 
understandable patient information for research studies.6 
Qualitative research has identified user-involvement out-
comes in palliative care research, including increased 
knowledge, skills, confidence, personal support, and emo-
tional and practical demands.The need for users to cope 
with academic and clinical language has been highlighted 
as an issue to address. Heightened uncertainty regarding 
users’ roles in being involved in influencing research and 
the value of their contribution also needs attention.7 
Differences between the views and experiences of users 
and healthcare professionals are beginning to emerge more 
generally in healthcare. Ethnographic research revealed 
that some staff view involvement as a stepwise event with 
measurable processes and outcomes, while patients view 
involvement as a dynamic, collective process enabled 
through collaborative relationships with the aim of rapidly 
improving services.8
Knowing how best to implement user involvement in 
palliative care research is impeded by limited evidence on 
the best ways to enable involvement, and uncertainty about 
the differences and similarities between the views of users 
and researchers. Therefore, research is required to identify 
optimal concepts or models of user involvement within 
institutes (not just individual research studies) to maximise 
benefits and to ensure that effective involvement models, 
which reflect the needs and expectations of those involved, 
are implemented. Ineffective models may increase role 
uncertainty and compromise intended involvement out-
comes. Ineffective models may also increase emotional 
and practical demands unnecessarily on palliative care 
patients and their unpaid caregivers. Our research aims to 
determine an optimal user-involvement model through 
examining users’ and researchers’ priorities for user 
involvement in palliative care research. This study focuses 
on direct involvement of service users in palliative care 
research activities. The intended model seeks to identify 
characteristics of an optimal involvement model that fulfil 
the needs of both users and researchers while acknowledg-
ing any potential diversity between these groups.
Methods
Design
We used an abbreviated MORECare Transparent Expert 
Consultation approach consisting of only a modified 
nominal group technique in April 2014.9–12 This approach 
involved three presentations given to individuals inter-
ested in palliative care research. This was followed by 
focus group discussions and a nominal group technique 
rating exercise to generate recommendations and form a 
consensus on priority order to inform the components of a 
model of user involvement in palliative care research. 
Areas of divergence between users and researchers were 
identified in this process. The three presentations pro-
vided were: (1) the value of user involvement in palliative 
care research (presented by an academic expert); (2) the 
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history of user involvement in the research setting 
(S.d.W.-L. and K.N.) and (3) the workshop rules, pro-
cesses and purpose, which were to discuss and establish 
consensus regarding how user involvement might best be 
taken forward in palliative care research (C.M.). 
Participants were then split into smaller groups of three to 
five individuals with a facilitator to discuss three critical 
questions (Box 1). The questions had been circulated 
beforehand to ensure time for deliberation and considera-
tion prior to the consultation.
Following this, seven consultative steps of the nominal 
group technique were facilitated, involving small and 
larger group discussions and individual priority setting 
(Box 2).
Box 1. Three critical questions answered by users and researchers.
1. How can patients, families and the public contribute to research in order to improve its quality and relevance?
2. How might patient, family and public involvement work best in the Cicely Saunders Institute?
3. How can researchers and patients, families and the public benefit from patient, family and public involvement?
The workshop was facilitated by experienced research-
ers (S.d.W.-L. and J.W.) and user advocates (K.N. and 
C.M.). Regular research supervision was provided (by 
B.A.D.) and all were trained in the study requirements. 
Box 2. Seven steps completed in the consultation according to the nominal group technique.
1. In each small group, each participant silently wrote down their ideas in response to each of the three questions.
2.  Each participant shared their ideas in a round-robin fashion, until all ideas for each question had been shared within the small 
group.
3.  Participants were asked to discuss the ideas for clarity and overlaps. Duplicates were removed and similar ideas combined. 
Participants were encouraged to discuss and clarify each idea in relation to previous experiences of involvement.
4.  Based on this smaller-group discussion, each small group produced a composite list of ideas for each question, ranked in 
order of importance.
5.  Composite lists produced in the small groups were then shared with all participants, and all participants were encouraged to 
discuss each idea on each list to ensure every idea was understood from a common perspective.
6.  Ideas from all small groups were collated to produce one manageable and comprehensive final list that outlined all ideas for 
the three questions. This involved deleting duplicates and merging similar suggestions into one idea, where feasible.
7.  Each participant was asked to individually rank the five most important ideas for each question in order of one (most 
important) to five (least important) using a ranking sheet with the final ideas for each question included in the list.
The facilitators had no prior relationships with most par-
ticipants. The researchers had existing professional rela-
tionships with most researcher participants. An active 
partnership approach between user representatives and 
researchers was used throughout the project.
Setting
The research was conducted at the Cicely Saunders 
Institute (CSI) at King’s College London.
Consent
Potential participants were initially approached by 
familiar staff (already working in the research setting) 
with study information. If interested, further contact was 
made by phone or post, and then a formal workshop invi-
tation was issued. Those interested then registered for 
the workshop and an information pack containing the 
three research questions was issued. In the interests of 
inclusive enquiry, the two service-user advocates who 
helped facilitate the consultation contributed their pri-
orities. Written informed consent was obtained for all 
participants on the day of the workshop (by S.d.W.-L. 
and J.W.).
Inclusion or exclusion criteria
Inclusion criteria were the ability to provide informed con-
sent to understand written and spoken English to a degree 
that allowed workshop participation and active involve-
ment in CSI palliative care research. Travel expenses for 
user participants were reimbursed. A gift voucher (£15) 
was given to them at the end of the workshop. The users 
had no knowledge of this voucher before agreeing to par-
ticipate in the workshop.
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Sample size
In line with expert guidance, practical judgement and experi-
ence were used to determine a sample size that would enable 
deep and sufficient analysis of the questions.13 A sample of 
between 6 and 10 has been recommended for focus group 
discussions as this allows for variation in views to be shared, 
facilitated and managed.14 We aimed for this number as there 
are clear similarities between the processes of a nominal 
group technique discussion and focus group discussions. In 
order to achieve the sample size, we approached 35 service 
users and 32 researchers to participate in the study.
Analysis
Individual rankings were transferred into an Excel sheet 
for separate group analysis (J.W., S.d.W.-L. and B.A.D.). 
Consensus was defined as items ranked within the top 
five by ⩾50% of the participants. These items were ana-
lysed (thus excluding items prioritised by the minority). 
The median and interquartile range (IQR) were calcu-
lated and compared for each of these items to produce a 
ranked list of recommendations for each question. 
Deductive content analysis15 of the audio recordings ena-
bled the following: (1) identification and comparison of 
reasons for involvement priorities, (2) identification of 
involvement methods for implementation and (3) inter-
pretation of quantitative findings. Deductive analysis 
was done once the quantitative findings were established. 
This involved listening to the recording and searching 
deductively for statements for each question and for any 
mention of involvement methods. These data were typed 
verbatim into a word document. Illustrative statements 
were then presented alongside the quantitative findings 
in order to convey comprehensiveness and details.
Rigor and quality
Regular research meetings and user-representative involve-
ment aided analysis and credibility. Data inputting and analy-
sis were double checked. Agreement was established between 
authors to verify authenticity of the qualitative component.
Ethics
Ethical approval was obtained from the King’s College 
London’s Research Ethics Committee (BDM/13/14-97).
Results
A total of 12 users and 5 researchers were recruited. 
The two most common reasons for not participating were 
having little time and scheduling difficulties. User partici-
pants were four patients (two with cancer and two with a 
non-malignant condition); four unpaid caregivers; two 
user advocates and two members of the public involved in 
care provision, research governance and/or service com-
missioning. Research participants were a clinical research 
nurse, two research assistants, one clinical–academic PhD 
fellow and a senior scholar. Participants generated 47 rec-
ommendations across the three questions (Table 1).
Question 1: how can patients, families and 
the public contribute to research in order to 
improve its quality and relevance?
A total of 14 recommendations were generated (Table 1).
Users. The first consensus priority was widening the scope of 
palliative care research beyond cancer to ensure involvement 
of those with non-malignant conditions and the public (M = 2, 
IQR = 1–3, n = 9; Table 2). The second priority was user 
involvement at each stage of the research (M = 3, IQR = 1.75–
5, n = 8), especially early on to influence idea generation and 
study design (M = 3, IQR = 3–4, n = 7). Users clarified that 
researchers should come to them asking ‘“What should we be 
studying?” [not] “We are studying these”’ (Public 1). Users 
wanted their involvement to be more visible with a greater 
emphasis on the difference their involvement makes (M = 4, 
IQR = 2.5–4.5, n = 7). For example, they wanted to be more 
heavily involved in the dissemination of findings. They 
shared the importance of receiving meaningful feedback 
regarding whether and how their contribution helped, which 
necessarily involves feedback from researchers:
[the researcher] sends an email and they say ‘yes this is the 
situation, we’ve taken on board [what you’ve said] and we’ve 
changed this or that’ … It makes you feel that this isn’t in vain 
… It’s worth continuing … makes you feel as though you 
want to come to the next one. (Patient 1)
Researchers. The first priority was that involvement can 
improve palliative care research by identifying research 
bias and ensuring quality (M = 1, IQR = 1–1, n = 3): ‘… by 
making sure we haven’t missed anything informed by our 
own experience … to help identify systematic biases that 
we are unable to see …’ (Researcher 1). The second prior-
ity was involvement in idea generation and study design to 
aid research quality and relevance (M = 2, IQR = 1.75–
2.25, n = 4): ‘… having brought patients and the public into 
the research after the research has been designed is really 
unsatisfactory for everyone’ (Researcher 2). The third pri-
ority was involvement can aid dissemination and increase 
impact (M = 4, IQR = 3.75–4.25, n = 4; Table 2).
Question 2: how might patient, family and 
public involvement work best in the CSI?
A total of 18 recommendations were generated (Table 1).
Users. The top priority was involvement would work best 
if researchers could establish and lead on providing and 
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Table 1. A total of 47 recommendations generated by all participants for ranking.
Research questions Recommendations generated for ranking
Question 1: how can patients, families and the public 
contribute to research in order to improve its quality 
and relevance?
 1. Dissemination and increasing impact
 2.  Early involvement in idea generation and study design, before the 
idea is thought of ask patients/families/the public
 3. Flexible and responsive research templates
 4.  Making involvement visible beforehand, during and after research 
(what difference did it make?)
 5. Listen, respond and act continuously at all stages of research
 6.  Involvement in the complete research continuum (from start to 
finish)
 7. Widen to public and other illnesses (not just cancer)
 8. Partnerships (e.g. with other societies and organisations)
 9. Need to be involved/access for everyone
10. Define terms/avoid jargon
11. Engagement
12.  Communication and advertising to get as many people as possible 
involved
13. Helping to identify researcher bias and ensuring quality
14.  Providing specific feedback (e.g. on grant applications, outputs and 
study materials)
Question 2: how might patient, family and public 
involvement work best at the CSI?
 1.  Wide access, ensuring diversity (aiming for representativeness) 
and have the facilities to support diversity
 2.  ‘Pick and mix’, that is, wide variety of ways to get engaged, 
flexibility in engagement and different levels of engagement
 3.  Collaboration with other organisations and charities, reaching out 
to people and wide advertising
 4.  Make it visible, show its value (and make people feel valued) and 
show its impact (i.e. actions taken in response to patient/family/
public involvement and their feedback)
 5. Access to palliative care for everyone
 6.  CSI takes the lead role in implementing understanding of palliative 
care for lay people, ensure people understand the same thing by 
‘palliative care’ and get people talking about it
 7.  CSI looking outwards and tells the world about involvement and 
get people talking about it
 8.  User champions embedded within the CSI to lead, facilitate and 
ensure true engagement and involvement happens
 9. Ensure people understand what research takes place currently
10. Rewards and thank you token for participants
11.  Personalise involvement and make appropriate for lay people 
(avoid jargon)
12.  Ensure user voice is equal and everyone feels safe and able to 
share their expertise
13. User involvement from the start (early involvement)
14. Shared learning from other research user-involvement initiatives
15.  Well-planned and properly funded (potential guidelines for 
researchers on patient/family and public involvement)
16.  Support and training for researchers, organisational recognition 
and shared learning
17.  Support and training for patients/families/public members of 
research partnership team and clear communications from CSI
18.  Regular monitoring evaluation and feedback on impact of 
involvement
Question 3: how can researchers and patients, 
families and the public benefit from patient/family and 
public involvement?
 1.  Mutual understanding and benefit for both researchers and 
patients/family/public
 2. Practical impact through feedback mechanisms
 3. Creation of a wider network due to knowledge gained
 4. Intrinsic and truthfulness (not tokenism involvement)
 5. Use social networking and coordinate across platforms
 (Continued)
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Research questions Recommendations generated for ranking
 6.  Take lead in coordinated communications (talking and listening) 
and tell people why it is important to get patients/families/the 
public involved
 7.  Demystify perceptions of palliative care and raise awareness of 
palliative care and research
 8. Shared understanding
 9. Teamwork
10. Improved confidence in knowledge and research (truthfulness)
11. Influencing the agenda
12. Sharing more widely, even if negative
13.  Reduce research wastage and increase relevance (improve future 
care)
14.  Opportunity to share experience (among researchers and 
patients/family/public)
15.  Empowerment, recognition and contribution of patient/family/
public contributions
CSI: Cicely Saunders Institute.
Table 1. (Continued)
implementing a shared understanding of what palliative 
care is (M = 1.5, IQR = 1–3.5, n = 6) as this would help 
advance the field of palliative care (Table 3). The second 
priority was the need for a flexible involvement model 
with a wide variety of ways to become and remain engaged 
with various levels of intensity to accommodate individu-
als’ competing demands (M = 3, IQR = 1.5–3, n = 7):
It’s a matter of timing when you work with family members 
and carers because going through the process of supporting 
somebody with fighting whatever condition they have and 
possibly looking at the end of their life they [the patient] are 
your sole concern … research doesn’t matter when you’re just 
trying to get through chemo or get the district nurse in. 
(Caregiver 3)
Methods to implement were shared:
Be a member of a network, which responds to requests for 
ideas, comments, etcetera by post and online, and be 
available to take part in focus groups … have a wide 
offering to people so that they can pick and mix what they 
want to do. (Caregiver 1)
The importance of using different platforms was rec-
ommended: ‘Twitter is a start but it needs to be coordi-
nated across all of the platforms’ (Patient 2).
Researchers. Researchers also prioritised a flexible 
involvement approach as their top priority (M = 1, IQR = 1–
2, n = 3) and acknowledged that this requires effort (Table 
3):
… allowing for people to dip in and out depending on how 
their disease progresses or how their caring responsibilities 
progress … so to take on lighter tasks or more intense 
involvement at times … there’s also an element of making an 
effort to find out what people prefer. (Researcher 5)
Researchers prioritised diverse involvement (M = 2, 
IQR = 2–3, n = 5) as this helps extend the research focus 
and responsiveness:
Our questions might become focussed on the people that 
we have got in the groups … maybe we are always 
focussing on areas that we have always focussed on … to 
bring new voices and new experiences into that group. 
(Researcher 4)
Researchers recommended instituting adequate facili-
ties and funding for involvement, especially to support 
diverse involvement (M = 2, IQR = 1.5–2.5, n = 3):
If it’s not properly funded and we’re not really given the time 
to do it properly or adequately that’s when it becomes very 
unsatisfying for the people you are engaging as well as for the 
researchers themselves. (Researcher 1)
Researchers indicated that involvement would work 
best if a collaborative approach with other organisations 
and charities was taken – reaching out to people and using 
wide advertising (M = 5, IQR = 5–5, n = 5):
Helping us translate the research that we do into patient-, 
family- and also policy-relevant findings. Sometimes we have 
patients and families living with a particular condition … they 
have very good links with support groups for people with that 
condition and they have a good understanding of what other 
organisations might be relevant in terms of disseminating 
findings. (Researcher 1)
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Question 3: how can researchers and patients, 
unpaid caregivers and the public benefit 
from patient, unpaid caregiver and public 
involvement?
A total of 15 recommendations were generated (Table 1).
Users. The highest level of agreement for question 3 was 
demystifying perceptions of palliative care and raising 
awareness of palliative care and research (M = 2, IQR = 1–
2.5, n = 8; Table 4). Users suggested methods to achieve 
involvement diversity, suggesting early recruitment via 
general practitioner (GP) surgeries, via different social 
media platforms (such as Facebook) and through proactive 
personal contact in the community:
Rather than waiting for the patients to come to you … You’re 
not just a patient when you’re in hospital are you?! You’re a 
patient when you’re at home … when you’re doing your 
shopping … You can ignore telephone calls … posters … 
emails but you can’t ignore a person. Whatever type of 
engagement it’s just better to have that personal [approach] … 
(Public 1)
Users wanted to take a lead in coordinated communica-
tions and let people know why involvement is important in 
research (M = 2, IQR = 2–2, n = 9): ‘The power is in the 
personal voice of implementation’ (User-advocate 1). The 
third priority was wide dissemination of research findings, 
even if the results were negative (M = 3.5, IQR = 2.25–
4.75, n = 6): ‘because it all influences care’ (Public 1). For 
users, dissemination was inextricably linked with impact 
and benefit: ‘There are only three words [that matter]: con-
tribute, involve and benefit’ (Caregiver 5). Practical meth-
ods to evaluate impact were shared:
You put in your ideas about what’s important to you as a 
person with [a type of condition] or as a carer of someone 
with [a type of condition] and then the priorities are chosen 
and then the next stage is proposals that have been put in for 
funding. You grade them on a smiley-face scale from one to 
10 … then the results of our assessment plus the results of the 
scientists’ assessment who have seen whether the research is 
good science or not, come together. (Caregiver 1)
Researchers. Researchers’ top priority was research effi-
ciency and relevance to improve care (M = 1, IQR = 1–4, 
n = 4): ‘… it has really helped that there are some people 
[users] who bring us back to what we were actually trying 
to find out, bringing us back to our research question and 
objective and making us stick to that agenda’ (Researcher 
5; Table 4). Another clarified that ‘At the end of the day it’s 
[involvement] going to reduce research wastage as you’re 
not answering pointless questions’ (Researcher 2). The sec-
ond priority was demystifying palliative care and raising 
awareness (M = 3, IQR = 2–3, n = 5). The third priority was 
users taking a lead in coordinated communications and 
sharing the importance of involvement (M = 4, IQR = 3–4, 
n = 3), ensuring that people understand the research.
Discussion
Our study identifies four key elements essential for an 
optimal model of involvement and corresponding methods 
for palliative care research. First, researchers must pro-
mote the contribution that users deliver and emphasise the 
difference that they make. This sustains engagement and 
aids user satisfaction. To help achieve this, researchers 
need to clearly define palliative care and communicate 
clearly about it. Clear agreement about what constitutes 
palliative care  will help users demystify palliative care 
and disseminate findings to others. Second, early involve-
ment (i.e. getting people involved as close to or even 
before the start of a project) is fundamental to improving 
research productivity, quality and relevance. Third, a 
model that involves a high degree of flexibility is essential. 
Diverse virtual and face-to-face methods are needed 
because of disease fluctuation and progression, and unpaid 
caregiver priorities and responsibilities. Suitable methods 
include the following: proactive community engagement 
strategies, letters via generalist providers, focus groups, face- 
to-face meetings, online forums, tools to measure impact 
and social media platforms. Fourth, users should be 
encouraged to add value through enhancing productivity, 
and improving quality and relevance, as this is prioritised 
by researchers.
Users and researchers were clear that early involvement 
is essential. However,  research has shown that when users 
first become involved in research, they may not be entirely 
sure about their roles and what they might hope to achieve.4 
Therefore, we recommend that time be devoted to clarify-
ing roles early on. There also needs to be  scope to develop 
roles throughout projects. We suggest that an initial rela-
tionship- and knowledge-building phase be considered to 
induct new users. This recommendation corresponds with 
ethnographic data that has shown that collaborative rela-
tionships are important to service users.8 This phase can be 
facilitated through flexible, needs-based, face-to-face train-
ing programmes coupled with remote learning opportuni-
ties.4 Good national, pump-primed, capacity-building 
demonstration projects have been implemented in pallia-
tive care and these can be used as examples to develop 
future work (such as the Complex Interventions: 
Assessment, Trials and Implementation of Services 
(COMPASS) collaborative16).
Our findings demonstrated that users and researchers 
believe that involvement can demystify palliative care and 
raise awareness within the general public – helping to 
move palliative care beyond cancer. Participants agreed on 
the need for palliative care to focus more solidly on those 
living with non-malignant conditions. Therefore, through 
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public involvement, death and dying in society may be 
more frequently discussed. The denial of death and dying 
in society has been identified as a major barrier to achiev-
ing high-quality palliative care research.17 User involve-
ment may therefore have far-reaching benefits, and it may 
help address an intractable problem for the field. 
Although both users and researchers prioritised the 
need for early involvement, only the users prioritised 
involvement throughout the entire research continuum (i.e. 
from start to finish). This result is similar to findings from 
a study that inolved cancer patients in commissioning ser-
vices.18 (Table 2). But many patients involved in the plan-
ning phases of a palliative care research project may die by 
the time the study has been completed. They will therefore 
miss out on being involved in disseminating findings. 
Many patients involved in palliative care research will also 
experience disease fluctuation which may compromise 
involvement. Similarly, demands on unpaid caregivers 
will fluctuate according to the needs of their beloved ones. 
Our findings therefore suggest that different users may be 
need to be involved in different stages of a palliative care 
research project. Plus, different involvement methods may 
need to be used at different stages. For example, a focus 
group with many may be facilitated initially to generate 
research ideas. This might be followed by email communi-
cation with key individuals to help refine a grant proposal 
and then another focus group with different users to aid 
interpretation of the research findings. 
In our study, it was also shown that researchers are 
acutely aware of and prioritise user involvement to 
improve productivity and therefore reduce waste, for 
example, by avoiding researching an irrelevant need to the 
population. Researchers agreed on the importance of this. 
The IQR for this item for researchers was nil (i.e. IQR 
1-1). But this was not a priority for the users (Table 4). 
Users may therefore need guidance and encouragement 
from researchers to deliver this priority. Billions of dollars 
of research investment are wasted every year because of 
correctable problems with research. Having users shape 
the healthcare research agenda is one way to help address 
these types of inefficiencies.19 Our study highlights poten-
tial savings that can be made in palliative care research 
because of patient and public involvement. Therefore, 
investing in palliative care involvement infrastructure may 
produce a substantial return on investment.
Strengths and limitations
A limitation of this research is the study sample. Only 
users already involved in research and known to the CSI 
participated in this study. They were all English speakers. 
One of the findings from our project was the need to 
increase involvement diversity in future work. Achieving 
the right mix for research into the development of an 
involvement model such as ours is a significant challenge. 
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Another limitation was that very senior investigators, for 
example, those who lead on large programme grants, were 
missing from the consultation. Also, we used an ordinal 
ranking scale for our nominal group work rather than an 
interval scale. An interval scale would have allowed for a 
more thorough examination and understanding of the dif-
ferences between the individual rankings.
Conclusion
Researchers should ensure visibility of involvement, stress 
its impact and provide clarity regarding the definition of 
palliative care. Users are to be encouraged to remain 
focussed on adding value to research through concentrat-
ing on improving research productivity (efficiency), qual-
ity and relevance. Implementation, effectiveness and 
cost-effectiveness research is required to examine the out-
comes of this involvement model. Early and flexible 
involvement opportunities need to be offered for involve-
ment in palliative care research to succeed. Involvement in 
dissemination should also be encouraged.
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